No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Chemicals - Specialty
Pondy Oxides And Chemicals Limited (POCL) functions primarily as a secondary lead smelting enterprise. The company's comprehensive product portfolio encompasses various lead metals and alloys, as well as zinc metal and zinc oxides, which it supplies to markets both within India and abroad. Additionally, POCL offers specialized master, tin, and babbit alloys, alongside a range of PVC additives. Its principal customer base consists of manufacturers in the battery and chemical industries, as well as producers of extruded and molded PVC goods. Beyond its domestic operations, POCL maintains a substantial international presence, exporting its products to countries including Japan, South Korea, Thailand, Indonesia, nations across the Middle East, and other global destinations. The firm, which has its corporate headquarters in Chennai, India, was incorporated in 1995.
www.pocl.comNo one on the platform currently holds POCL.BO.
No tracked institution reports a position in POCL.BO as of their last filing.
No one on the platform has traded POCL.BO yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
| Metric | Historical average | My assumptions | ||||
|---|---|---|---|---|---|---|
| 1 year | 5 years | 10 years | Low | Mid | High | |
| ROIC % | 14.6% | 15.6% | 14.4% | — | — | — |
| Rev. Growth % | 43.8% | 24.1% | ||||
| Profit Margin % | 4.5% | 3.5% | 3.0% | |||
| Free Cash Flow Margin % | -3.4% | -1.7% | -1.3% | |||
| Exit P/E | — | — | — | |||
| Exit P/FCF | — | — | — | |||
| Desired Annual Return % | — | — | — | |||
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2028 | $54.0B | — | $31.00 | $31.00–$31.00 | — | 1 |
| 2029 | $10.9B | -79.9% | $19.31 | $19.31–$19.31 | — | 1 |
| 2030 | $12.3B | +13.0% | $22.53 | $22.53–$22.53 | — | 1 |
| 2031 | $29.9B | +144.0% | $44.50 | $44.50–$44.50 | — | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| POCL.BOPondy Oxides And Chemicals Limited | $434.95 | -4.30% | $33.2B | — |
| ADVENZYMES.BOAdvanced Enzyme Technologies Limited | $288.60 | -1.87% | $32.4B | — |
| ADVENZYMES.NSAdvanced Enzyme Technologies Limited | $287.90 | +0.07% | $32.2B | — |
| CAMLINFINE.BOCamlin Fine Sciences Limited | $99.20 | -2.55% | $19.0B | — |
| CAMLINFINE.NSCamlin Fine Sciences Limited | $99.21 | +0.00% | $19.1B | — |
| GRAUWEIL.BOGrauer & Weil (India) Limited |
Source: Financial Modeling Prep · peers by sector/industry
| $73.13 |
| -3.76% |
| $33.2B |
| — |
| NEOGEN.BONeogen Chemicals Limited | $2307.35 | -3.28% | $60.7B | — |